To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Combination of Mesenchymal Stem Cells & Platelet-Rich Plasma for Knee Osteoarthritis

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2023

Combination of Mesenchymal Stem Cells & Platelet-Rich Plasma for Knee Osteoarthritis

Vol: 303| Issue: 1| Number:3| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Combination of mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) in the treatment of knee osteoarthritis: a meta-analysis of randomised controlled trials

BMJ Open. 2022 Nov 16;12(11):e061008

Contributing Authors:
J Zhao G Liang Y Han W Yang N Xu M Luo J Pan J Liu LF Zeng

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Six controlled clinical trials containing a total of 493 patients with knee osteoarthritis were included in this systematic review and meta-analysis comparing the combination of mesenchymal stem cells and platelet-rich plasma (n=204) with control (n=289; mesenchymal stem cells, platelet-rich plasma, or hyaluronic acid alone). Pooled outcomes of interest included pain on a Visual Analog Scale (VAS)...

Join the Conversation

Please Login or Join to leave comments.